Inozyme Pharma Banner Image

Inozyme Pharma

  • Ticker INZY
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Inozyme Pharma Logo Image
  • 51-200 Employees
  • Based in Boston, Massachusetts
Inozyme Pharma is a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Their lead product candidate is INZ-701, an enzyme replacement therapy (ERT) in the early stages of clinical development for the potential treatment of patients with a variety of calcification disorders linked primarily to mutations in the ENPP1 and ABCC6More genes, or ENPP1 Deficiency and ABCC6 Deficiency respectively.
Inozyme Pharma

Most Recent Annual Report

Inozyme Pharma
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Inozyme Pharma Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!